(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/bzh75q/external_beam) has announced the addition of the "External Beam Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering.
The global external beam radiation therapy devices market was worth $3,308.6 million in 2012 and is expected to reach $4,304.9 million in 2017, growing at a CAGR of 5.4% from 2013 to 2017.
External beam radiotherapy market is primarily driven by electron emitting high energy linear accelerators, followed by compact advanced radiotherapy systems and proton therapy systems. In comprehensive compact advanced radiotherapy market, Gamma Knife holds the major share presently compared to CyberKnife and TomoTherapy devices. As accuracy is the main concern for the intracranial treatment to protect sensitive neighbouring tissues, Gamma Knife was always the first choice of the physician for its huge popularity. Proton machine market is highly dominated by huge cyclotron machines. The rest of the market is occupied by synchrotron machines. Comprehensiveness of entire cyclotron system is the major driver for this market.
A LINAC or linear accelerator is the most important component of external beam therapy devices and perpetual variations and development in their characteristics such as electron-emitting high energy machines and proton therapy machines have rendered scope for the evolution of different types of external beam therapy. Further miniaturization of devices has led to introduction of radiosurgery systems such as Gamma Knife, TomoTherapy and CyberKnife. Radiosurgery systems though being a small contributor, they are the most technologically advanced area in the external beam therapy systems market. Synchrotron and cyclotron systems have a wide range of applications and high contribution to the field of radiation oncology.
External beam radiation therapy forms the major part of all radiotherapy procedures, being given principal importance over the other two technologies namely internal beam radiation or brachytherapy and systemic radiation therapy. Continuous technical upheaval combined with efficient reimbursement support from developed countries of North America and Europe are the major reasons for this huge external beam radiation therapy market growth.
In terms of technology, IMRT procedure has become a standard for treatment in prostate cancer, CNS and head and neck cancer due to its multiple targets, multiple critical avoidance and differential weightages to critical tissues. The considerable penetration of IGRT and other advanced technologies that significantly answer the growing demand of obtaining real time pictures during treatment procedures for better outcomes has marred the market growth of IMRT. However, healthy reimbursement policies and governmental support will continue to drive this market significantly in the coming years.
Rapid introduction of new therapeutic technologies of radiotherapy have made this market dynamic in nature.
Key Topics Covered
- Introduction to the Report
- Market Synopsis
- Market Dynamics
- Products Market Size & Forecast - Global External Beam Radiation Therapy Devices - Applications Market Size & Forecast - Global External Beam Radiation Therapy Devices - Technology Market Size & Forecast - Global External Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global External Beam Radiation Therapy Devices - Key Players Analysis: External Beam Radiation Therapy Devices Market, 2012 (%) - Company Profiles
- Ion Beam Applications
- ProTom International
- Siemens Healthcare
- Varian Medical Systems
For more information visit http://www.researchandmarkets.com/research/bzh75q/external_beam
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Research and Markets,